Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-course glucocorticoid regimens for glucocorticoid-dependent immune thrombocytopenia
ChiCTR2000030603Phase 4Recruiting
- Sponsor
- Second Affiliated Hospital of Kunming Medical University
- Start
- May 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of eltrombopag, rituximab, azathioprine and cyclosporine in immune thrombocytopenia (ITP) (6 arms), sponsored by Second Affiliated Hospital of Kunming Medical University. Primary endpoint: Platelet count. Started May 2020; status: recruiting.
02
Drugs
eltrombopagrituximabazathioprinecyclosporine
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on ChiCTR2000030603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000030603.